NEWTON, Mass.–(BUSINESS WIRE)–Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells,…
Article Source
https://www.biospace.com/press-releases/abcuro-to-present-two-posters-at-the-american-academy-of-neurology-2025-annual-meeting